Akero Therapeutics, Inc. Common Stock(AKRO)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$54.70
52-Week Range
$41.77 – $57.35
IV Rank (30D)
100
Straddle Price
$0.00
P/C Vol Ratio
0.55
Market Cap
$4.5B
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$4.5B

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

Price History
Seasonality
MonthAvg ReturnYears of Data
Jan +17.12% 5
Feb +1.24% 5
Mar -12.92% 5
Apr -0.69% 5
May +1.03% 5
Jun +9.28% 5
Jul -0.62% 5
Aug +7.25% 5
Sep +33.16% 5
Oct -8.48% 5
Nov +6.50% 5
Dec +9.69% 5
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $54.38
SMA 50: $52.92
SMA 200: $48.17
Current: $54.65
EMA 12: $54.47
EMA 26: $54.03
MACD: 0.4404 | Signal: -0.1039
BULLISH
ADX (14): 35.99
TREND
+DI: 28.69
−DI: 14.58
Momentum Oscillators
RSI (14): 69.15
NEUTRAL
Stoch %K: 75.76
Stoch %D: 84.44
Williams %R: -28.93
Volume & Volatility
BB Upper: $54.68
BB Lower: $54.08
NEUTRAL
OBV: 85,041,304
Vol SMA 20: 2,419,174
Vol ROC: 1263.16%
ATR: $0.29
True Range: $0.46
HV 20: 2.3%
HV 30: 2.8%
HV 60: 38.8%

Data Summary
Data Points: 500
Last Updated: 2026-06-12T21:15:11.653000
Date Range: 2023-12-11T00:00:00 – 2025-12-08T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
5 of 5 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-08-09 After-Close 8.19% 2.22% 0.27x Within
2024-11-08 Pre-Market 9.07% 0.76% 0.08x Within
2025-01-27 After-Close 28.17% 22.51% 0.80x Within
2025-05-12 Pre-Market 11.15% 4.09% 0.37x Within
2025-08-08 After-Close 12.98% 4.32% 0.33x Within
Options Activity
IV Rank (30D)
100
IV Rank (7D)
100
Avg IV
176.5%
Straddle (30D)
$0.00
Straddle (7D)
$0.00
P/C Volume
0.55
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Volatility Surface

Enter a ticker to render the implied volatility surface.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
0.33
Correlation (SPY)
9.2%
0.01
Ann. Volatility
39.7%
SPY Volatility
11.0%

Low volatility - stock moves less than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

6 filers79,992 shares$3.80M value
# Filer Shares Value % of Total % of Float Period
1 AXA Investment Managers S.A. 71,200 $3.38M 89.03% 2025-09-30
2 WOLVERINE TRADING, LLC Custodian 5,059 $240.91K 6.34% 2025-09-30
3 Point72 (DIFC) Ltd 3,693 $175.33K 4.62% 2025-09-30
4 Essential Partners LLC 5 $267 <0.01% 2025-06-30
5 Hemington Wealth Management 7 $0 0.00% 2025-09-30
6 Keating Financial Advisory Services, Inc. 28 $0 0.00% 2026-03-31
1 filers$433.34K notional
# Filer Notional Value % of Total Period
1 WOLVERINE TRADING, LLC Custodian $433.34K 100.00% 2025-09-30
1 filers$352.39K notional
# Filer Notional Value % of Total Period
1 WOLVERINE TRADING, LLC Custodian $352.39K 100.00% 2025-09-30
Insider Activity
Latest: 2025-12-09
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2025-12-09 Yuan Xu Director Disp (D) −9,398 EDGAR
2025-12-09 Tomas J. Heyman Director Disp (D) −9,398 EDGAR
2025-12-09 Jonathan Young Chief Operating Officer Disp (D) −260,189 EDGAR
2025-12-09 Jane Henderson Director Disp (D) −9,398 EDGAR
2025-12-09 Mark T Iwicki Director Disp (D) −9,398 EDGAR
2025-12-09 Scott A. Gangloff Chief Technology Officer Disp (D) −26,351 EDGAR
2025-12-09 Patrick Lamy See Remarks Disp (D) −29,891 EDGAR
2025-12-09 G. Walmsley Graham Director Disp (D) −1,302,398 EDGAR
2025-12-09 William Richard White Chief Financial Officer Disp (D) −57,752 EDGAR
2025-12-09 Andrew Cheng President and CEO Disp (D) −436,837 EDGAR
2025-12-09 Catriona Yale Chief Development Officer Disp (D) −74,800 EDGAR
2025-12-09 Timothy Rolph Chief Scientific Officer Disp (D) −282,149 EDGAR
2025-12-09 Seth Loring Harrison Director Disp (D) −293,762 EDGAR
2025-12-09 Chou Judy Director Disp (D) −9,398 EDGAR
2025-11-28 Timothy Rolph Chief Scientific Officer Exer (M) +152,678 $4.09 $624.1K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
14 insiders · @ $54.65
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Versant Venture Capital VI, L.P. 10%+ Owner 7,297,318 $398.80M -$24.20M 8 2020-07-10
2 ATP III GP, Ltd. 10%+ Owner 5,830,203 $318.62M $29.88M 1 2020-07-14
3 Aaron Royston Director 3,954,858 $216.13M $4.00M 1 2019-06-25
4 COREY S GOODMAN 10%+ Owner 3,940,534 $215.35M -$1.72M 1 2020-01-03
5 Versant Ventures VI GP-GP, LLC 10%+ Owner 3,309,616 $180.87M -$4.28M 1 2020-01-06
6 Montrago Trustees Ltd 3,271,829 $178.81M -$284.66M 1 2022-12-05
7 venBio Global Strategic GP II, L.P. 10%+ Owner 3,229,548 $176.49M $11.23M 4 2020-02-27
8 venBio Global Strategic GP II, Ltd. 10%+ Owner 3,160,319 $172.71M -$59.45M 4 2020-03-06
9 Versant Ventures VI GP, L.P. 10%+ Owner 3,118,638 $170.43M -$6.91M 2 2020-01-21
10 Robert J Adelman 10%+ Owner 3,033,552 $165.78M -$35.50M 4 2020-07-06
11 Atlas Venture Fund XI, L.P. 10%+ Owner 2,706,412 $147.91M $0 1 2020-01-02
12 Jeremy Green 10%+ Owner 743,802 $40.65M $0 1 2019-06-24
13 Atlas Venture Associates Opportunity I, L.P. 10%+ Owner 505,099 $27.60M $25.92M 1 2019-06-25
14 Atlas Venture Opportunity Fund I, L.P. 10%+ Owner 404,079 $22.08M $0 2 2020-02-10
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.